IL33 and cancer: The role of IL-33 in cancer is most likely context-dependent because it demonstrates either an anti-tumorigenesis effect (e.g., pancreatic cancer, ovarian, and colon cancer) or a pro-tumorigenesis effect (e.g., breast cancer, lung cancer) [20,23].